Jun 2025
Conyers acted as Cayman Islands legal counsel to Jyong Biotech Ltd. (“Jyong”) for their initial public offering and listing of ordinary shares on the Nasdaq stock exchange.
Jyong is a Taiwan-based biotechnology company dedicated to developing and commercialising unique and botanical drugs, targeting markets in the U.S., EU, and Asia.
Partner Anna Chong and Associate Michael Yu of Conyers’ Hong Kong office advised on the matter working alongside Sichenzia Ross Ference Carmel LLP and underwriter Joseph Stone Capital, LLC.